We studied mRNA expression levels and cellular localization of several maternal and embryonic factors in unfertilized oocytes and preimplantation stage embryos^[@R9]-[@R13]^, namely, *Hsf1, Brg1, Bmi1, Pou5f1*, *Sall4*, *Esrrb, Apobec1, Aid* and *Tet1*. We initially normalized *Gapdh* expression and confirmed that mRNA levels were statistically similar in intact and enucleated embryos and protein was evenly distributed in nuclei and cytoplasm^[@R14]^ ([Extended Data Fig. 1a, b, c](#F1){ref-type="fig"}). No significant differences in expression levels of these genes existed between intact and enucleated interphase zygotes and I2C embryos ([Extended Data Fig. 1d](#F1){ref-type="fig"}). Bmi1, Hsf1 and Brg1 proteins were also equally distributed throughout the cells and, therefore, enucleation does not seem to deplete these factors in the cytoplasm ([Extended Data Fig. 2a, b](#F2){ref-type="fig"}).

Success in mammalian SCNT has been attributed to the use of G0/G1 arrested donor nuclei with mature, unfertilized oocytes naturally arrested at MII as the recipient cytoplasm^[@R1],[@R15]^. The slight cell cycle mismatch in this case could presumably be corrected shortly after SCNT by nuclear envelope breakdown followed by premature chromosome condensation induced by M-phase specific factors present in the cytoplast^[@R16]^. Thus, both the donor nucleus and recipient cytoplasm resume coordinated embryonic cell divisions after artificial activation of SCNT embryos. In clarifying the importance of cell cycle matching to reprogramming success, we established a timing of cleavage initiation, from which the cell cycle of the recipient I2C cytoplasm could be assessed, individually. Then, we carefully timed the onset and progression of the mitotic cell cycle during the transition from zygote to the 2-cell stage embryo. Most zygotes entered first mitosis between 29 and 35 hrs post-hCG administration and formed centrally localized, metaphase spindles detectable with polarizing microscopy. Zygotes progressed quickly through anaphase and telophase culminating in cell division and formation of the 2-cell embryo. Approximately 30 min after the onset of cleavage, 2-cell embryos formed nuclei that were visible microscopically, corroborated by nuclear envelope detection using lamin B immunocytochemistry. Nuclei became more prominent by 60 min after cleavage and increased in size during the next 10 hours ([Fig. 1a, b, c](#F7){ref-type="fig"}). Incorporation of 5-bromo-2′-deoxyuridine (BrdU), an indicator of S-phase, was first detected approximately 3-4 hrs after cleavage onset and was evident in embryos up to 7-8 hours after cleavage. Embryos labeled after 8 hrs post cleavage did not incorporate BrdU suggesting their transition into the G2 phase ([Fig. 1b](#F7){ref-type="fig"}). The majority of mouse 2-cell embryos completed the full cell cycle and entered into the next M-phase approximately 18-20 hrs after first cleavage. Thus, we determined a complete cell cycle of a mouse 2-cell embryo starting with the initial cleavage (0 hrs) and onset of the G1 phase. The G1 phase concluded and DNA synthesis and the S phase were initiated approximately 3 hrs from the end of the previous M-phase. The S phase ended by 8 hrs and blastomeres entered the G2 phase lasting a minimum of 9 hrs ([Fig. 1d](#F7){ref-type="fig"}). We next determined the cell cycle characteristics of two nuclear donor cell types: fetal fibroblasts (FFs) and ESCs, and sorted populations for G0/G1, G2/M and S phase cells ([Extended Data Fig. 3](#F3){ref-type="fig"}).

We then examined SCNT into enucleated I2Cs ([Fig. 2a](#F8){ref-type="fig"}). When G0/G1 phase FFs were introduced into early G1 (0.5-1hrs) enucleated blastomeres, 38% of reconstructed SCNT embryos progressed to blastocysts. This rate was comparable to conventional SCNT of G0/G1 FFs into enucleated MII oocytes (40%), although significantly reduced over fertilized controls (94%; [Table 1](#T4){ref-type="table"}). When G0/G1 FFs were fused into intermediate (1-2 hrs) or late (2-3 hrs) G1 enucleated blastomeres, blastocyst development significantly declined ([Table 1](#T4){ref-type="table"}) and transfer of G0/G1 FFs into S phase I2C cytoplasm (4-6 hrs) or M-phase zygotes (0 hrs) resulted in developmental arrest. When actively proliferating FFs in S phase were introduced into S phase blastomeres, 24% of the resultant SCNT embryos reached the blastocyst stage. We also used ESCs and cumulus cells for nuclear transfer and observed significant blastocyst development when our matching criteria were satisfied ([Table 1](#T4){ref-type="table"}). To examine a possible role for sperm activated cytoplasm in interphase SCNT success, we generated enucleated parthenogenetic I2Cs and carried out SCNT with FFs, observing blastocyst development comparable to SCNT into fertilized counterparts or into conventional MII oocytes ([Table 1](#T4){ref-type="table"}). Thus, both artificial and sperm activated cytoplasm of I2C support reprogramming. Arrest of cell cycle mismatched SCNT embryos could be secondary to nuclear arrest or apoptosis at the G1/S or S/G2 cell cycle checkpoints^[@R17]^ ([Extended Data Fig. 4](#F4){ref-type="fig"}).

We utilized FFs carrying the GFP transgene under the control of *Oct4* promoter^[@R18]^ and beta-galactosidase^[@R19]^ to confirm the origin of the nucleus in cloned embryos. GFP signal was not detectable after fusion with I2C cytoplasm ([Fig. 2b](#F8){ref-type="fig"}). Re-expression of the GFP transgene was observed in late 4-cell embryos that continued into the compact morula. As expected, GFP expression was confined to the inner cell mass having disappeared in the trophectoderm ([Fig. 2b](#F8){ref-type="fig"}). Nuclear donor FFs weakly expressed Brg1 ([Extended Data Fig. 2b, c](#F2){ref-type="fig"}) and a similar signal was found in nuclei of 2-cell SCNT embryos shortly after introduction ([Fig. 2c](#F8){ref-type="fig"}). However, Brg1 protein became increasingly detectable in the nuclei of SCNT embryos, 3 and 12 hrs post transfer, and in the 4- and 8-cell stage ([Fig. 2c](#F8){ref-type="fig"} and [Extended Data Fig. 2d](#F2){ref-type="fig"}).While Hsf1 was not detected in FFs, the protein was expressed in SCNT embryos ([Extended Data Fig. 2b, c, d](#F2){ref-type="fig"}). To examine expression of candidate reprogramming factors in SCNT embryos generated with I2C cytoplasm, we also measured mRNA levels for *Apobec1*, *Aid* and *Tet1*. Expression patterns and levels of *Apobec1* and *Tet1* were comparable to fertilized controls (*p* \< 0.05), with the exception of the 8-cell stage, where *Tet1* was up-regulated in SCNT embryos. *Aid* transcript levels were significantly lower in SCNT embryos compared to controls ([Fig. 2d](#F8){ref-type="fig"}).

The developmental potential of embryos produced by SCNT with FFs into enucleated I2Cs was evaluated further by plating blastocysts (n=26) onto feeder layers. All adhered, eight formed typical ICM outgrowths and, after subsequent passaging, seven stable ntESC lines (27%), with typical colony morphology and expression of Oct4 and SSEA-1 were established ([Fig. 3a](#F9){ref-type="fig"} and [Extended Data Table 1](#T1){ref-type="table"}). Similarly, 3 ntESC lines were generated from 14 blastocysts (21%) following interphase SCNT with cumulus cells ([Extended Data Table 1](#T1){ref-type="table"}). With FFs carrying *Oct4*-GFP as nuclear donor cells, the resulting ntESCs re-expressed GFP at high levels ([Fig. 3a](#F9){ref-type="fig"}). We confirmed normal karyotype and gender in all ntESC lines ([Extended Data Table 1](#T1){ref-type="table"}) and corroborated their nuclear DNA origin from somatic cells and mitochondrial DNA inheritance from I2C cytoplasm ([Fig. 3b](#F9){ref-type="fig"} and [Extended Data Fig. 5a, b](#F5){ref-type="fig"} and [Extended Data Table 1](#T1){ref-type="table"}). The ability to form chimeric offspring was evaluated by random selection of female ntESCs derived from FFs (ntES2) and injection into diploid (2N) 8-cell embryos. After transfer into recipients, 14 pups were born, 10 of which were chimeric based on a coat color contribution of ntESCs on an albino background of host ICR embryos ([Extended Data Table 2](#T2){ref-type="table"}). The chimera rate varied from 5% to more than 90% as determined by visual evaluation. Pups produced by breeding chimeric females with control males displayed germline transmission of the ntESC genotype ([Extended Data Fig. 5c](#F5){ref-type="fig"}).

We ~~also~~ tested ntESCs for the ability to generate all-ESC offspring by tetraploid (4N) complementation^[@R20]^. After transfer of 165 tetraploid embryos injected with ntES2 cells, 5 live pups were recovered, of which 4 survived to adulthood and exhibited exclusively the ntESC coat color phenotype ([Extended Data Fig. 5d](#F5){ref-type="fig"}, [Table 2](#T3){ref-type="table"}). We corroborated the all-ntESC origin of these mice by microsatellite and mtDNA genotyping ([Extended Data Fig. 5a, b, e](#F5){ref-type="fig"}). Quantitative mtDNA analysis was characterized by the absence of any detectable contribution from host 4N embryos ([Extended Data Fig. 5b](#F5){ref-type="fig"}). Additionally, two ntESC lines derived from adult cumulus cells contributed to chimeras using both 2N and 4N complementation assays ([Fig. 3c, d](#F9){ref-type="fig"} and [Extended Data Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). These stringent pluripotency tests confirm that ntESCs derived by SCNT into enucleated I2C blastomeres are the equivalent of embryo-derived ESCs.

Embryos produced by nuclear transfer into I2C cytoplasm were evaluated for totipotency by direct transfer into uteri of pseudopregnant females. When 115 SCNT blastocysts generated with FFs were transferred into 10 recipients, four became pregnant and showed implantation sites, but none contained viable fetuses ([Extended Data Table 3](#T3){ref-type="table"}). An explanation for failed pregnancy may be the absence of a histone deacetylase inhibitor which is essential to efficient live offspring production in conventional SCNT with MII oocytes^[@R21]^. However, when 89 nuclear transfer blastocysts generated with ESC nuclei carrying a LacZ transgene were transferred, four live pups were recovered by caesarean section ([Extended Data Fig. 6a](#F6){ref-type="fig"}, [Table 3](#T3){ref-type="table"}). Their body and placental weights varied significantly ([Extended Data Fig. 6b](#F6){ref-type="fig"}). Whole body X-gal staining confirmed the nuclear transfer origin of the offspring ([Fig. 3f](#F9){ref-type="fig"}) and placenta ([Fig. 3g](#F9){ref-type="fig"}). In addition, cloned offspring and their placentas carried *LacZ* and *GFP* transgenes ([Extended Data Fig. 6c](#F6){ref-type="fig"}).

Interphase nuclear transfer into fertilized embryos has resulted in live offspring when pronuclei were exchanged between two zygotes^[@R4]^ and when 4 or 8-cell blastomere nuclei were transferred into enucleated 2-cell embryos^[@R22]^. However, nuclear transfer of more advanced ICM cells, ESCs or somatic cells into interphase cytoplasm resulted in early developmental arrest, likely reflecting mismatched cell cycles^[@R5],[@R7],[@R22],[@R23]^. Nuclear transfer of 4-16-cell blastomeres into enucleated MII oocytes has also resulted in live offspring in several species including nonhuman primates^[@R24]-[@R27]^. This approach required pre-activation of the recipient cytoplast prior to nuclear transfer resulting in exit from the M-phase and progression to the interphase^[@R24],[@R28]^. Since most randomly chosen nuclear donor blastomeres were also in interphase, synchronization between the nucleus and cytoplast was likely achieved.

The present findings, suggest that the interphase cytoplasm has reprogramming capacity and that precise cell cycle synchrony between donor and recipient can lead to development of functional ESCs or live offspring. This supposition would argue against the premise that SCNT failures involving interphase cytoplasm are secondary to the absence of critical maternal factors removed during enucleation. In view of the present results in the mouse and the unsuccessful attempt to conduct SCNT into human M-phase zygotes^[@R29]^, SCNT into human 2-cell embryos with proper cell cycle matching should be reconsidered.

Methods {#S2}
=======

Preparation of nuclear donor cells {#S3}
----------------------------------

The carcass of a fourteen day fetus was collected and treated with 0.1% collagenase for 30 min. The digested tissue was cultured with 10% FBS and 100 ug/ml penicillin/ streptomycin in DMEM. Early passages (2-4) FFs were used for SCNT. For G0/G1 phase, cells were seeded in 4-well plates, and cultured for 1 week with 0.5% FBS medium. For S phase, G0/G1 arrested FFs were seeded at low density in ESC growth medium (see below), and cultured for 20 hours. The cumulus-oocyte complexes were collected from superovulated females 18-20 hrs after hCG injection (see below) and briefly exposed to a medium containing 0.1% hyaluronidase for disaggregation. Dispersed cumulus cells were rinsed and kept in KSOM medium (Millipore) before use.

ESCs and FFs were fixed overnight in 70% ethanol, washed in DPBS and stained with 10 μg/ml propidium iodide (Sigma) in DPBS for 1 hr on ice for flow cytometric analysis (BD Biosciences, LSRII flow cytometer). FFs were either arrested at G0/G1 by culture to confluency under low serum conditions or forced to proliferate and enter S phase after re-plating G0/G1 arrested cells at low density in medium containing serum. In confluent FFs, nearly 79% of the cells were at G0/G1, 3% were at S and 18% were at G2/M phase. However, after sorting by size (small ≤12 μm, large ≥16 μm), small sized FFs were enriched for G0/G1 cells (91%). In proliferating FFs, the proportion of S phase cells was significantly increased (70%). We also confirmed S phase by 30 μM BrdU (BD PharmingenTM) incorporation for 30 min BrdU after 3.7% formaldehyde fixation. There was no significant correlation between cell size and cell cycle phase distribution in proliferating FFs. In actively proliferating ESCs, 27% were at G0/G1, 47% at S and 26% at the G2/M phase. When ESCs were sorted based on size, approximately 70% of small cells (≤9 μm) were G0/G1. In contrast, most medium sized cells (10-15μm) were in S phase (BrdU+) while a significant percentage of large cells (≥16 μm) were in the G2/M phase. Based on these observations, most small sized ESCs and confluent FFs were in the G0/G1 phase, while proliferating FFs or medium sized ESCs were predominantly at the S phase.

Cell cycle determination in recipient embryos {#S4}
---------------------------------------------

Pronuclear stage zygotes were collected from superovulated, mated females and continuously examined before and after the first cleavage division by Hoffman modulation contrast and polarized microscopy. Selected embryos were also fixed and labeled with antibodies against Lamin B and DAPI to follow nuclear membrane and chromatin dynamics, respectively. To define the onset of the S phase, we sampled every hour after the onset of cleavage into the 2-cell stage with 5-bromo-2′-deoxyuridine (BrdU) that incorporates into newly synthesized DNA during replication. The embryos were incubated in100 μM BrdU for 20 min with the remaining steps carried out according to the manufacturer\'s instructions before embryo observation by fluorescence microscopy (×400).

Interphase 2-cell SCNT {#S5}
----------------------

Nuclear transfer of FFs, ESCs or cumulus cell into interphase, enucleated 2-cell blastomeres was undertaken with defined matches between the cell cycle of the recipient cytoplasm and the transplanted nucleus. *In vivo* fertilized, pronuclear stage zygotes were recovered and continuously monitored for the onset of cleavage. Two-cell blastomeres enucleated within 0.5-3 hrs after the onset of cleavage were considered G1 cytoplasts while enucleations conducted 4-6 hrs after the first mitosis were defined as S phase. Both blastomeres were enucleated under Hoffman contrast microscopy, and an intact nuclear donor cell was introduced into each enucleated blastomere using the fusogenic activity of HVJ-E ([Fig. 2b](#F8){ref-type="fig"} and [SI video](#SD1){ref-type="supplementary-material"}).

Derivation and culture of ESCs {#S6}
------------------------------

The zona pellucida was removed with acidic Tyrode\'s solution (Sigma-Aldrich) and denuded blastocysts were placed onto mitomycin C (Sigma) treated mouse embryonic fibroblast (mEF) feeder layers in ESC derivation medium: KO DMEM (Invitrogen) containing 15% KOSR (Invitrogen), 5% FBS (HyClone), mitogen-activated protein kinase inhibitor (PD98059; Cell Signalling) and 1,000 units/ml LIF (Sigma). After ICM outgrowth, the cultures were dispersed into single cells using trypsin and seeded on fresh mEFs in complete ESC medium: KO DMEM, 1 mM L-glutamine, 100 units/ml penicillin/100 μg/ml streptomycin, 100 μM β-mercaptoethanol (Sigma), 100 μM nonessential amino acids (Invitrogen), 1,000 units/ml LIF, 10% FBS and 10% KOSR.

Chimera Assay and embryo transfer {#S7}
---------------------------------

Approximately 10 ESCs were injected into 4-8 cell embryos recovered from B6D2F1 females mated with C3H males for 4N embryo complementation or from ICR for 2N chimeras. Injected embryos were cultured one day in KSOM. SCNT or chimeric blastocysts were transferred into the uteri of pseudo-pregnant (E2.5) ICR females. Caesarian section was performed on gestational days 18.5 through 20.5.

Genotyping analyses {#S8}
-------------------

Genotyping primers, D1Mit26, D10Mit3 and D14Mit10 were obtained from MGI (mouse Genome Informatics, [www.informatics.jax.org](http://www.informatics.jax.org)). GFP, LacZ, and mitochondrial analysis primers are described in Extended Data table 9. DNA was extracted from tail tips using Arcturus Microgenomics reagent kit (Applied Biosystems) or from cultured cells using a DNA kit (Gentra SYSTEMS). PCR products were separated by 3% agarose gels and visualized by ethidium bromide staining.

PCR products were sequenced and the informative single nucleotide polymorphic (SNP) sites were identified using Sequencher v. 4.7 software (GeneCodes). Allele Refractory Mutation System quantitative PCR (ARMS-qPCR) assays were performed to measure mtDNA heteroplasmy levels in chimeric offspring as previously described^[@R30]^. Primers and TaqMan MGB probes were designed to detect unique mtDNA regions between wild type and PWD/ph mtDNA. CO3 (common mtDNA region)-TET (yellow) and ND5 (wild specific mtDNA region)-FAM (blue) were mixed and measured with Rotor-Gene Multiplex PCR Kit (Qiagen). PCR reactions (15μl) containing 1× PCR Master Mix, 100-250 nM each primer, 150 nM each TaqMan probe and either 0.5 and 4 ng of total genomic DNA were performed according to the manufacturer\'s instructions using a ABI 7900HT fast real-time PCR system (Applied Biosystems).

X-gal staining {#S9}
--------------

Fetuses and placenta (E18.5) were removed by caesarian section and fixed overnight in 3.7% formaldehyde at 4°C, washed three times in PBS, cleared in 70% ethanol followed by incubation in 30% sucrose at 4°C overnight, embedding (Tissue-Tek OCT compound; Sakura Finetechnical) and freezing on dry ice. Sagittal sections (10 μm) were cut at -18°C with a cryostat (Leica Instrument). The specimen was stained overnight at 37°C in X-gal (1mg/ml), potassium ferricyanide (5 mM), potassium ferrocyanide (5 mM), MgCl~2~ (2 mM) in PBS.

Analysis of gene expression {#S10}
---------------------------

Total RNA was isolated and pooled from 10 embryos for each experiment (MII oocytes \[18 h\], interphase \[one cell, 24-26 h\], M-phase \[one cell, 28-30 h\], 2 cell \[31-33 h\], 2 cell cytoplast \[nuclei removed, 31-33 h\], 4 cell \[50-52 h\], 8 cell \[66-68 h\], 16 cell \[74-76 h\], and blastocyst \[98-100 h\]) with an Arcturus pico pure RNA isolation kit (Life technologies). RNA was immediately treated with DNase I (Invitrogen) and reversed into cDNA using the SuperScript III first-strand synthesis system (Invitrogen) according to the manufacturer\'s instructions. RT-PCR was performed using an ABI 7900HT Real time PCR system and the SYBR Green PCR mix (Applied Biosystems). The samples were heated to 95 °C for 10 min and run for 40 cycles of: 94 °C for 15 s, 58°C for 20 s, 72°C for 30 s. Gene expression was normalized to *Gapdh*.

Immunostaining {#S11}
--------------

Embryos were labeled with antibodies for Brg1 (SC-10768), Lamin B (SC-6217), Bmi1 (SC-30943) and Hsf1 (SC-9144). ESCs were stained with antibodies for Oct4 (SC-30943) and SSEA-1(SC-21702). Secondary antibodies were coupled with FITC or Cy3 and DAPI was used for counterstaining nuclei. All antibodies were purchased from Santa Cruz.

Western blot {#S12}
------------

Embryos were collected and washed three times in TBS and transferred into 7 μl of RIPA extraction buffer supplemented with protease inhibitors. Protein samples were diluted with 2.5 μl sample buffer and 1 μl reducing agent, incubated 10 min at 70°C, and size separated using 4-12% Bis-Tris Mini Gel (novex, Life technologies). Proteins were blotted into polyvinylidene fluoride (PVDF) membranes (Hybond-P, GE Healthcare). Nonspecific binding was blocked by blocking solution (Invitrogen) at room temperature for 1 h. Membranes were probed 1h at room temperature with primary antibody (1:200 rabbit anti-Brg1; SC-10768, 1:200 rabbit anti-Hsf1; SC-9144, 1:5000 rabbit anti-Gapdh; G9545, Sigma). Primary antibodies were detected with a HRP-conjugated secondary antibody (1:10,000 goat anti-rabbit) applied for 1 h at room temperature and developed with Femto Maximum Chemiluminescent Substrates (SuperSignal 34095; Thermo Scientific).

Statistical analysis {#S13}
--------------------

All data are presented as average ± s.d. One-way ANOVA was used to compare differences among groups followed by post comparison between groups by Bonferroni using IBM SPSS statistics 20 software.

Primer information {#S14}
------------------

Gene

Primer (5′-3′)

Remarks

Beta-actin

F-AGCCATGTACGTAGCCATCC

R-CTCTCAGCTGTGGTGGTGAA

Gapdh

F-CCACCCAGAAGACTGTGGAT

R-CACATTGGGGGTAGGAACAC

Brg1

F-CTGCGTAAGATCTGCAACCA

R-TTGGCAAAAGAGGAGCACTT

Bmi1

F-TGTCCAGGTTCACAAAACCA

R-TGCAACTTCTCCTCGGTCTT

Hsf1

F-CCAGCAGCAAAAAGTTGTCA

R-GTAGGCTGGAGATGGAGCTG

Aid (Aicda)

F-GGTACCTGGGAGTCGTTTGA

Bhutani et al., 2010

R-GGTGAATGCCACTTTCCCTA

Apobec1

F-AAGGATACCACCCCATCTCC

R-CCCTACCCATGAATGACACC

Tet1

F-GAGCCTGTTCCTCGATGTGG

Ito et al, 2010

R-CAAACCCACCTGAGGCTGTT

Pou5f1

F- GACTCCACCTCACACGGTTC

May et al., 2009

R- CAGACCACCATCTGTCGCT

Sall4

F- CGACCACCCAAGTATTGCCAG

Wang et al., 2001

R- AGGTGCAACAAGTCAGAGGAA

Esrrb

F- TGGACTCGCCGCCTATGTTCG

Mitsunaga et al., 2004

R- ACTTGCGCCTCCGTTTGGTGA

ROSA26-LacZ

F- CTTGTGATCCGCCTCGGAGTATT

Matthew et al, 2004

R- CGCGCCGCTGTAAAGTGTTACGT

GFP

F- TGCAGTGCTTCAGCCGCTAC

R- TCGCCCTCGAACTTCACCTC

mtCO3

F-TCTAGCCTC GTA CCA ACA CAT GAT

ARMS qPCR

R-TGAAACACCTGATGCTAGAAGTACTGA

mtPWD/ph-ND2

F-ACTGCACATAGGACTTATTCTTGTC

ARMS qPCR

R-TTGAGTAGCGGGTAGATTAGG

mtWild-ND5

F-CCTACTAATTACACTAATCGCCACT

ARMS qPCR

R-GAGGTCTGGGTCATTTTCGTTA

mtCommon-ND5

F-TGCAACACCAACGCCTGAGCC

R-TTGTGTGAAGAGTTGAGGTGG

mtPWD/ph-ND5

F-CTAATCACACTAATTGCCACC

R-GTAGTAAGTGGCGTAATGTGG

mtWild-ND5

F-TTCCACCAACCAACATTCCAA

R-ATAATAAGTGGCGTAATGTGG

Extended Data {#S15}
=============

![Maternal and embryonic gene expression patterns\
**a**, Immunocytochemical detection of Gapdh signal demonstrated even distribution in nuclei and cytoplasm in MII oocytes and interphase zygotes and 2-cell embryos. **b**, Expression of *Gapdh* normalized to *β-actin*. No significant differences were seen between intact and enucleated 2-cell embryos (4 replicates each containing pooled RNA from 5 embryos, *p* \> *0.05*). **c**, *Gapdh* expression was relatively low and constant with no significant differences seen until the 8-cell stage. Expression was increased in 16-cell embryos and blastocysts (3 replicates each containing pooled RNA from 10 embryos, \**p \< 0.05*). **d**, Gene expression of the transcriptional regulators *Bmi1, Hsf1*, *Brg1, Sall4* and *Esrrb,* transcription factor *Pou5f1,* and epigenetic factors *Apobec1, Aid* and *Tet1* during mouse preimplantation embryo development. The level of expression for *Brg1, Apobec1, Pou5f1, Sall4, Aid, Tet1* and *Esrrb* underwent dramatic increases at or after the 4-cell stage. The red bars indicate enucleated oocytes, zygotes or 2-cell embryos. No significant differences were observed between intact and enucleated counterparts (n=3 biological replicates, *p* \< *0.05*). Gene expression was normalized to *Gapdh*. Error bars indicate average ± s.d., MII = Metaphase II arrested oocyte, Z =Zygote, I = Interphase, M = mitotic, Cyto = Cytoplast.](nihms566194f1){#F1}

![Protein expression of candidate reprogramming factors\
**a**, Immunocytochemical detection of Bmi1, Hsf1 and Brg1 in zygotic interphase, M-phase and 2-cell interphase embryos. The expression pattern of these proteins was similar to that observed for mRNA expression ([Extended Data Fig. 1d](#F1){ref-type="fig"}). 2-cell-I phase embryos were fixed 4 hours after cleavage. **b**, Western blot detection of Brg1 and Hsf1 in nuclear donor cells, intact and enucleated 2-cell embryos (n=40). **c**, Immunocytochemical detection of Brg1 and Hsf1 in nuclear donor FFs and ESCs. **D**, Immunocytochemical detection of Brg1 and Hsf1 in SCNT embryos. Z = zygote, M = mitosis, MII-metaphase II acolyte, I = interphone, FFs = fetal fibroblasts, ESCs = embryonic stem cells.](nihms566194f2){#F2}

![Cell cycle determination in nuclear donor cells\
**a**, Confluent fetal fibroblast (FF) populations subjected to flow cytometric processing. After sorting by size and density, 91% of small sized cells were in the G0/G1 phase of the cell cycle. **b**, Proliferating FF populations were mostly at S phase. **c**, ESC populations by flow cytometry. The size was correlated with the cell cycle, 70% of the small, medium and large size cell were at G0/G1, S and G2/M, respectively. **d**, FITC conjugated-BrdU was used to define S phase FFs and ESCs. **e**, Correlation of cell size and cell cycle in FFs and ESCs. Cell size was measured photographically after 3.7% formaldehyde fixation. S phase cells were separated by BrdU integration (green). The assignments of cell size provided in panels **a**, **b** and **c** were defined from the results in panel E (\* *p* \< *0.05*), pFFs = proliferating fetal fibroblasts.](nihms566194f3){#F3}

![Nuclear staining of cell cycle matched and mismatched SCNT embryos\
Left panel - expanded nuclei of developmentally competent 2-cell SCNT embryos generated by transfer of S-phase FF nuclei into enucleated S-phase 2-cell embryo. Middle and right panels -- Condensed or dispersed nuclei of arrested SCNT embryos generated after cell cycle mismatch between donor nucleus and recipient cytoplasm. Embryos were arrested and apoptotic by the G1/S or S/G2 cell cycle checkpoints, respectively. SCNT embryos were fixed 15 hrs after cleavage.](nihms566194f4){#F4}

![Genotyping of chimeric mice\
**a**, Chromatogram of mtDNA depicting sequence differences at base pairs (bp) 11939, 12062 and 12122 and demonstrating that mtDNA in ntESCs was derived from recipient embryo cytoplasm. Sequence differences between chimera host embryos and ntESCs at 11939, 12199, 12002, 12005, 12008 and 12062 bp allowed quantification of chimerism. The mtDNA from 2N chimeric mouse appeared as a double peak. The 4N chimera showed only ntESC mtDNA (GeneBank AY172335.1). **b**, Allele Refractory Mutation System quantitative PCR (ARMS-qPCR) assay in 2N and 4N chimeras. Similar colors indicate similar origin. Distances between color plots represent the contribution of chimeric host embryos. Amplification plot (left) and bar graph (right). Detection limit of this assay is 0.01%. **c**, High ntESC contribution chimeric female and her pups demonstrating germline transmission. White spot on the head of the dam originated from the ICR host embryo. **d**, Tetraploid (4N) embryo complementation pups born after ntESC (black) injection into host 8-cell stage 4N embryos. **e**, Genotyping of 4N complementation pups.](nihms566194f5){#F5}

![Cloned offspring and genotyping\
**a**, Body and placenta of cloned and control pups delivered by caesarian section at 20 days. Clones and placentas were larger or smaller than controls. **b**, Genotyping of nuclear donor cells and cloned pups carrying ROSA26+/**-**OG2+/**-**. **c,** Fetal and placental weights (g) of cloned and control pups.](nihms566194f6){#F6}

###### Origin of ntESC lines generated by SCNT into enucleated interphase 2-cell embryos and their ability to contribute to chimeras

  ntESCs   Gender   Nuclear donor cells   Genotype of donor cells   mtDNA of donor cells   2-Cell embryo mtDNA   2N chimera   4N chimera
  -------- -------- --------------------- ------------------------- ---------------------- --------------------- ------------ ------------
  ntES1    M        FFs                   B6D2F1                    common                 PWD                   n/t          n/t
  ntES2    F        FFs                   129S1/SvlmJ               MOLF                   PWD                   yes          yes
  ntES3    M        FFs                   B6D2F1                    common                 PWD                   yes          n/t
  ntES4    M        FFs                   B6D2F1                    common                 PWD                   n/t          n/t
  ntES5    M        FFs                   B6D2F1                    common                 common                n/t          n/t
  ntES6    F        FFs                   Oct4-GFP                  common                 common                n/t          n/t
  ntES7    F        FFs                   Oct4-GFP                  common                 PWD                   n/t          n/t
  ntES8    F        CCs                   B6D2F1                    PWD                    PWD                   yes          yes
  ntES9    F        CCs                   B6D2F1                    PWD                    PWD                   n/t          yes
  ntES10   F        CCs                   B6D2F1                    PWD                    PWD                   n/t          n/t

n/t - non tested, FFs - fetal fibroblasts, CCs - cumulus cells.

###### Ability of ntESCs to contribute to chimeras after injection into diploid (2N) or tetraploid (4N) host embryos

  -----------------------------------------------------------------------------------------------
  Cell line      Host\     N     N recipients\   N\            N\         \>90%\      Survived\
                 embryo\         (pregnant)      Pups born\    chimeras   chimerism   \>90%\
                 type                            /recipients                          chimerism
  -------------- --------- ----- --------------- ------------- ---------- ----------- -----------
  ntES2          2N        217   12 (4)          14/4          10         5           3

  ntES2          4N        165   14 (6)          5/3           5          5           4

  ntES3          2N        250   13 (8)          12/4          12         3           1

  ntES8          2N        90    6(3)            9/3           9          8           7

  ntES8          4N        180   15(6)           7/3           7          7           6

  ntES9          2N        137   9(5)            5/3           5          5           4

  Control ESCs   4N        313   22(11)          19/6          19         19          4
  -----------------------------------------------------------------------------------------------

###### In vivo development of embryos derived by nuclear transfer into enucleated interphase 2-cell embryosor MII oocytes

  Nuclear donor cells   Recipient cytoplasm        N embryos transferred/recipients   N pregnant recipients   Live pups born (%)
  --------------------- -------------------------- ---------------------------------- ----------------------- --------------------
  FFs                   Interphase 2-cell embryo   115/10                             4                       0
  MII oocyte            170/10                     4                                  1 (0.6%)                
                                                                                                              
  ESCs                  Interphase 2-cell embryo   89/8                               3                       4 (4.5%)

FFs - fetal fibroblasts, ESCs - embryonic stem cells
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![Cell cycle progression in 2-cell mouse embryos\
**a**, Spindle and nuclear changes as a function of time after cleavage. The zygotic embryo began cleavage after going through a short telophase. We defined this event as 0 hrs in the cell cycle. The spindle disappeared gradually followed by nucleus formation and visible increase in size. DNA images were produced from fixed and stained with DAPI embryos, while spindle birefringence and HMC images were taken from live embryos. HMC = Hoffman modulation contrast. **b**, S phase determination in 2-cell embryos using BrdU incorporation and Lamin B staining for identification of nuclear membrane. **c**, Measurements of nuclear size as an indication of cell cycle progression (n=5, biological replicates, \* *p* \< *0.05*. Average diameter ± s.d.). **d**, The dull cell cycle timing in the 2-cell mouse embryo.](nihms566194f7){#F7}

![Development of mouse embryos generated by interphase SCNT\
**a**, Experimental design. Interphase SCNT conducted with 2-cell embryos followed by ntESC derivation or production of chimeric or cloned offspring. **b**, Oct4/GFP re-expression after interphase SCNT using transgenic fetal fibroblasts **c**, Brg1 and Lamin B protein expression in SCNT embryos. **d**, Expression of *Tet1, Apobec1* and *Aid* in control and SCNT embryos (n=3, technical replicates, \**p* \< *0.05*, average ± s.d.).](nihms566194f8){#F8}

![Characterization of ntESCs and live offspring born after interphase SCNT\
**a**, Morphology of ntESCs and expression of the pluripotency markers Oct4 and SSEA1 by immunostaining. Far right; re-expression of GFP in ntESCs derived from fetal fibroblasts carrying Oct4/GFP. **b**, Genotyping of ntESCs using chromosomal markers D1Mit26, D10Mit3 and D14Mit10. **c**, 2N chimeric pups generated by injection of ntESCs from cumulus cells (black) into ICR host embryos (albino). Note that two of the three pups contained exclusively ntESC phenotype. **d**, 4N complementation pups produced after injection of ntESCs (black) into tetraploid host embryo (agouti). **e**, Genotyping of chimeric offspring generated with ntESCs derived from cumulus cells by mtDNA profiling. All tetraploid and two of the three 2N chimeras contained ntESC mtDNA only. **f**, X-gal staining of control (non-stained, left) and cloned pup carrying LacZ gene (blue stained, right). **g**, X-gal detection of placental tissue section in cloned pups. Bar = 0.5 cm.](nihms566194f9){#F9}

###### In vitro development of embryos after nuclear transfer into enucleated interphase 2-cell blastomeres

  Recipient cytoplasm type                       Recipient cytoplasm cell cycle (hrs after cleavage)   Nuclear donor cell cycle   Donor cell type   N          Cleaved embryos (%)                        Blastocysts (%)
  ---------------------------------------------- ----------------------------------------------------- -------------------------- ----------------- ---------- ------------------------------------------ -----------------
  *In vivo* fertilized 2-cell embryos            M-phase                                               G0/G1                      FFs               55         2 (4)                                      0
  Early G1 (0.5-1)                               G0/G1                                                 FFs                        227               110 (48)   86 (38)                                    
  Intermediate G1 (1-2)                          G0/G1                                                 FFs                        56                12 (21)    8 (14)                                     
  Late (2-3)                                     G0/G1                                                 FFs                        37                5 (14)     4 (11)                                     
  S (4-6)                                        S                                                     FFs                        72                27 (38)    17 (24)                                    
  S (4-6)                                        G0/G1                                                 FFs                        34                0          0                                          
  Early G1 (0.5-1)                               G1                                                    ESCs                       161               63 (39)    53 (33)                                    
  Early G1 (0.5-1)                               S                                                     ESCs                       43                0          0                                          
  S (4-6)                                        S                                                     ESCs                       744               335 (45)   293 (39)                                   
  S (4-6)                                        G1                                                    ESCs                       34                3 (9)      2 (6)                                      
  Early G1 (0.5-1)                               G0/G1                                                 CCs                        257               58 (23)    39 (15)                                    
  Intact controls                                N/A                                                   N/A                        135               133 (99)   127 (94)[\*](#TFN2){ref-type="table-fn"}   
  Parthenogenetically activated 2-cell embryos   Early G1 (0.5-1)                                      G0/G1                      FFs               32         15 (47)                                    11 (34)
  Intact parthenote controls                     N/A                                                   N/A                        86                84 (98)    78 (91)[\*](#TFN2){ref-type="table-fn"}    
  MII oocytes                                    MII                                                   G0/G1                      FFs               289        161 (56)                                   116 (40)
  MII                                            G1                                                    ESCs                       113               46 (41)    25 (22)                                    
  MII                                            G0/G1                                                 CCs                        136               95 (70)    23 (17)                                    
  MII                                            S                                                     ESCs                       70                8 (11)     2 (3)                                      

Control versus experimental treatment within each group

*p* \< *0.05*.

FFs - fetal fibroblasts, ESCs - embryonic stem cells, CCs - cumulus cells.

[^1]: Present address: South Miyagi Medical Center, Miyagi, Japan
